Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Therapeutic Drug Monitoring Remove


July 2014
Tu Mo Su Sa Fr Th We
29 28 27 26 25 24 23

therapeutic drug monitoring Press Releases

  + XML/RSS  



By Biomiga Diagnostics
Biomiga Diagnostics will be presenting data on its population pharmacokinetic/Therapeutic Monitoring Device for Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), and Human chorionic gonadotropin (hCG) in personalized IVF treatment.

By Biomiga Diagnostics
Biomiga Diagnostics will be presenting data on its population pharmacokinetic/Therapeutic Monitoring Device designed for Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) with application to other protein therapeutics.

By Biomiga Diagnostics
Biomiga Diagnostics announces the development of lateral flow point-of-care Therapeutic Drug Monitoring (TDM) assays for Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). These findings will be presented at the AACR 2012

By Biomiga Diagnostics
Biomiga Diagnostics, maker of quantitative point-of-care tests for Therapeutic Drug Monitoring and biomarker testing to promote personalized medicine, today announced it is joining Astia, a global network serving women-led high growth start-ups.

All Press Releases

By kdm communications
Analytical Services International (ASI) at St George’s, University of London, UK, has been evaluating LoGiCal certified reference materials – a new product range from LGC Standards – for its therapeutic drug monitoring (TDM) services.

By Biomiga Diagnostics
Biomiga Diagnostics will be presenting data on its population pharmacokinetic/Therapeutic Monitoring Device for Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), and Human chorionic gonadotropin (hCG) in personalized IVF treatment.

By Biomiga Diagnostics
Biomiga Diagnostics will be presenting data on its population pharmacokinetic/Therapeutic Monitoring Device designed for Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) with application to other protein therapeutics.

By Biomiga Diagnostics
Biomiga Diagnostics announces the development of lateral flow point-of-care Therapeutic Drug Monitoring (TDM) assays for Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). These findings will be presented at the AACR 2012

By Biomiga Diagnostics
Biomiga Diagnostics, maker of quantitative point-of-care tests for Therapeutic Drug Monitoring and biomarker testing to promote personalized medicine, today announced it is joining Astia, a global network serving women-led high growth start-ups.



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share